Stoke Therapeutics STOK
Ownership & positioning
Who holds it, who is betting against it, and where the big money is moving
Short-sale volume as % of daily volume
Large-order net flow, last 20 sessions
Net of large-order buying minus selling, in USD. Over this window: −$8.10M (8 inflow days, 12 outflow days).
Net flow by order size, last 20 sessions
Super/Big orders approximate institutional-size trades; Mid/Small approximate retail-size trades. Net buy minus sell value in each bucket, summed over the window.
The five largest holders on file together own 39.9% of shares outstanding.
Largest holders
By investor type
Reported short interest has fallen from 20.11% to 16.54% of float over the last 6 biweekly reports (14 Aug 2026 to 30 Oct 2026).
Recent institutional activity
| Holder | Type | Period | Share change | New stake |
|---|---|---|---|---|
| BlackRock | Mutual Fund | 2026/Q3 | +470,474 | 9.7% |
| Vanguard Capital Management, LLC | Mutual Fund | 2026/Q3 | +146,480 | 4.2% |
| Victory Capital Management Inc. | Mutual Fund | 2026/Q3 | +62,073 | 0.2% |
| SYM Financial Corporation | Mutual Fund | 2026/Q3 | +60,071 | 0.1% |
| BVF Partners L.P. | Hedge Fund | 2026/Q3 | +1,061,411 | 5.5% |
| Nuveen Asset Management LLC | Insurance Company | 2026/Q3 | +115,683 | 0.2% |
| T. Rowe Price Group, Inc. | Mutual Fund | 2026/Q3 | +2,891,794 | 7.8% |
| EcoR1 Capital, LLC | Hedge Fund | 2026/Q3 | +635,000 | 1.1% |
| State Street Global Advisors | Mutual Fund | 2026/Q3 | +575,728 | 4.4% |
| BlackRock | Mutual Fund | 2026/Q3 | +491,643 | 9.1% |
| Wellington Management Group | Mutual Fund | 2026/Q3 | +423,601 | 5.4% |
| Citadel Advisors LLC | Hedge Fund | 2026/Q3 | +366,279 | 0.7% |
| First Trust Advisors L.P. | Mutual Fund | 2026/Q3 | +327,454 | 0.8% |
| Vanguard Capital Management, LLC | Mutual Fund | 2026/Q3 | +276,890 | 4.6% |
| Jane Street Group, LLC | Private Company | 2026/Q3 | +267,352 | 0.5% |
Institutional buy/sell activity by reporting period, largest moves first.
Insider transactions
| Date | Insider | Title | Transaction | Shares | Price | Held after |
|---|---|---|---|---|---|---|
| 1 Nov 2026 | Barry Ticho | Chief Medical Officer | Automatic Disposition | -7,195 | $26.99 | 11,864 |
| 1 Oct 2026 | Jonathan Allan | Corporate Secretary, Compliance Officer & General Counsel | Automatic Disposition | -627 | $26.33 | 20,598 |
| 30 Sep 2026 | Barry Ticho | Chief Medical Officer | Automatic Disposition | -1,051 | $26.16 | 19,059 |
| 22 Sep 2026 | Alexander Cumbo | Director | Other Derivative Acquisition | +39,674 | $26.11 | 39,674 |
| 31 Aug 2026 | Barry Ticho | Chief Medical Officer | Automatic Disposition | -5,545 | $31.06 | 20,110 |
| 17 Aug 2026 | Edward Kaye | Former Advisor & Director | Derivative Exercise and Sale | -12,567 | $32.47 | 124,557 |
| 17 Aug 2026 | Barry Ticho | Chief Medical Officer | Derivative Exercise and Sale | -4,767 | $32.47 | 25,655 |
| 17 Aug 2026 | Jonathan Allan | Corporate Secretary, Compliance Officer & General Counsel | Derivative Exercise and Sale | -2,861 | $32.47 | 21,225 |
| 13 Aug 2026 | Edward Kaye | Former Advisor & Director | Derivative Exercise and Retained | +13,683 | – | 124,557 |
| 13 Aug 2026 | Barry Ticho | Chief Medical Officer | Derivative Exercise and Retained | +5,233 | – | 25,655 |
| 13 Aug 2026 | Jonathan Allan | Corporate Secretary, Compliance Officer & General Counsel | Derivative Exercise and Retained | +3,139 | – | 21,225 |
| 2 Aug 2026 | Barry Ticho | Chief Medical Officer | Automatic Disposition | -7,176 | $29.45 | 20,422 |
| 15 Jul 2026 | Seth Harrison | Independent Director | Other Derivative Acquisition | +151,595 | $40.37 | 17,786 |
| 15 Jul 2026 | Seth Harrison | Independent Director | Other Derivative Disposition | -151,595 | $40.37 | – |
| 14 Jul 2026 | Thomas McCauley | Chief Scientific Officer | Other Derivative Acquisition | +225,000 | $29.91 | 225,000 |
| 30 Jun 2026 | Barry Ticho | Chief Medical Officer | Automatic Disposition | -7,228 | $33.27 | 27,598 |
| 15 Jun 2026 | Jonathan Allan | Corporate Secretary, Compliance Officer & General Counsel | Automatic Disposition | -1,457 | $29.95 | 18,086 |
| 2 Jun 2026 | Seth Harrison | Independent Director | Other Derivative Acquisition | +17,786 | $29.46 | 17,786 |
| 2 Jun 2026 | Arthur Levin | Independent Director | Other Derivative Acquisition | +17,786 | $29.46 | 17,786 |
| 2 Jun 2026 | Julie Smith | Independent Director | Other Derivative Acquisition | +17,786 | $29.46 | 17,786 |
From Form 4/Form 144 filings. Negative share counts are disposals (sales, gifts, or shares withheld for taxes); positive are acquisitions.
Short interest, by report
| Report date | Shares short | % of float | Days to cover |
|---|---|---|---|
| 30 Oct 2026 | 10,722,415 | 16.5% | 6.8 |
| 15 Oct 2026 | 10,256,830 | 15.9% | 12.3 |
| 30 Sep 2026 | 11,505,410 | 17.8% | 10.2 |
| 15 Sep 2026 | 11,150,236 | 17.3% | 17.3 |
| 31 Aug 2026 | 11,203,427 | 17.4% | 11.9 |
| 14 Aug 2026 | 12,978,102 | 20.1% | 12.7 |
No comments yet — be the first to weigh in on STOK.
Sign in to join the discussion.